BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)]. 1972

J Canivet

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

J Canivet
[Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
October 1972, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
J Canivet
[Therapeutic value of a new oral antidiabetic agent: gliclazide].
March 1978, La Clinica terapeutica,
J Canivet
[Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
October 1972, Lyon medical,
J Canivet
[Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
May 1976, Journees annuelles de diabetologie de l'Hotel-Dieu,
J Canivet
[Pharmacological action of a new oral antidiabetic drug].
January 1956, Bollettino della Societa italiana di biologia sperimentale,
J Canivet
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
January 1972, Marseille medical,
J Canivet
The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
October 1972, Arzneimittel-Forschung,
J Canivet
[Therapeutic results of the new oral antidiabetic drugs].
April 1958, Minerva medica,
J Canivet
Insulinotropic action of a new sulfonylurea: gliclazide.
March 1972, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
J Canivet
[Gliclazide: review of metabolic and vascular action].
November 1994, Diabete & metabolisme,
Copied contents to your clipboard!